Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  Circulatory system drugs >  Antiarrhythmics Drugs >  OXPRENOLOL HYDROCHLORIDE

OXPRENOLOL HYDROCHLORIDE

Basic information Safety Supplier Related

OXPRENOLOL HYDROCHLORIDE Basic information

Product Name:
OXPRENOLOL HYDROCHLORIDE
Synonyms:
  • LABOTEST-BB LT00772178
  • 1-[2-(ALLYLOXY)PHENOXY]-3-[ISOPROPYLAMINO]-2-PROPANOL HYDROCHLORIDE
  • OXPRENOLOL HYDROCHLORIDE
  • 1-(o-allyloxyphenoxy)-3-isopropylamino-2-propanohydrochloride
  • dl-Alprenolol hydrochloride
  • dl-Oxprenolol hydrochloride
  • Laracor
  • Oxiprenolol hydrochloride
CAS:
6452-73-9
MF:
C15H24ClNO3
MW:
301.81
EINECS:
229-260-5
Product Categories:
  • Amines
  • Aromatics
  • Intermediates & Fine Chemicals
  • Pharmaceuticals
Mol File:
6452-73-9.mol
More
Less

OXPRENOLOL HYDROCHLORIDE Chemical Properties

Melting point:
91-93°C
storage temp. 
Store at +4°C
solubility 
Very soluble in water, freely soluble in alcohol.
CAS DataBase Reference
6452-73-9(CAS DataBase Reference)
More
Less

Safety Information

Hazard Codes 
Xi
RIDADR 
UN 2811 6.1 / PGIII
RTECS 
UA5277000
HazardClass 
IRRITANT
HS Code 
2922190900
Toxicity
LD50 oral in rat: 214mg/kg
More
Less

OXPRENOLOL HYDROCHLORIDE Usage And Synthesis

Description

Oxprenolol is an orally bioavailable β-adrenergic receptor (β-AR) antagonist (Ki = 7.10 nM in a radioligand binding assay using rat heart tissue). It is non-selective and binds to both β1- and β2-ARs (Kds = 2.09 and 1.35 nM in isolated rat heart and uterus, respectively). Oxprenolol is selective for β-ARs over serotonin (5-HT) receptors in rat sarcolemmal membrane preparations (IC50s = 4.13 and 23,300 nM, respectively), but it binds to 5-HT1A receptors in rat hippocampus and 5-HT1B in rat striatum (Kis = 94.2 and 642 nM, respectively). Formulations containing oxprenolol have been used to treat hypertension and angina pectoris.

Chemical Properties

White Solid

Originator

Trasicor,Ciba Geigy ,Italy,1970

Uses

Antihypertensive;Adrenergic receptor antagonist

Uses

β-Adrenergic blocker. Antihypertensive, antianginal, antiarrhythmic.

Manufacturing Process

75 grams of pyrocatechol monoallyl ether, 75 grams of epichlorohydrin, 75 grams of potassium carbonate and 400 ml of acetone are stirred and heated at the boil for 12 hours. The potassium carbonate is then filtered off. The solvent is distilled off in a water-jet vacuum. The residual oil is dissolved in ether and agitated with 2 N sodium hydroxide solution. The ether is separated, dried and distilled off. The residue is distilled in a water-jet vacuum. 3-(ortho-allyloxy-phenoxy)-1,2-epoxypropane passes over at 145° to 157°C under 11 mm Hg pressure. A solution of 15 grams of 3-(ortho-allyloxyphenoxy)-1,2-epoxypropane and 15 grams of isopropylamine in 20 ml of ethanol is refluxed for 4 hours. The excess amine and the alcohol are then distilled off under vacuum, to leave 1-isopropylamino-2-hydroxy-3-(orthoallyloxy-phenoxy)-propane which melts at 75° to 80°C after recrystallization from hexane.

brand name

Trasicor (Novartis).

Therapeutic Function

Antiarrhythmic

Biological Activity

Non-selective β -adrenergic antagonist.

Clinical Use

Beta-1 adrenoceptor blocker:
Hypertension
Angina
Arrhythmias
Anxiety

Drug interactions

Potentially hazardous interactions with other drugs
Anaesthetics: enhanced hypotensive effect.
Analgesics: NSAIDs antagonise hypotensive effect.
Anti-arrhythmics: increased risk of myocardial depression and bradycardia; increased risk of bradycardia, myocardial depression and AV block with amiodarone; increased risk of myocardial depression and bradycardia with flecainide.
Antidepressants: enhanced hypotensive effect with MAOIs.
Antihypertensives: enhanced hypotensive effect; increased risk of first dose hypotensive effect with post-synaptic alpha-blockers such as prazosin; increased risk of withdrawal hypertension with clonidine; increased risk of bradycardia and AV block with diltiazem; severe hypotension and heart failure occasionally with nifedipine; asystole, severe hypotension and heart failure with verapamil.
Antimalarials: increased risk of bradycardia with mefloquine.
Antipsychotics: enhanced hypotensive effect with phenothiazines.
Cytotoxics: possible increased risk of bradycardia with crizotinib.
Diuretics: enhanced hypotensive effect.
Fingolimod: possibly increased risk of bradycardia.
Moxisylyte: possibly severe postural hypotension.
Sympathomimetics: severe hypertension with adrenaline and noradrenaline (especially with nonselective beta-blockers) and possibly with dopamine.

Metabolism

Oxprenolol is extensively metabolised in the liver, direct O-glucuronidation being the major metabolic pathway and oxidative reactions minor ones. Oxprenolol is excreted chiefly in the urine (almost exclusively in the form of inactive metabolites).

OXPRENOLOL HYDROCHLORIDESupplier

J & K SCIENTIFIC LTD.
Tel
010-82848833 400-666-7788
Email
jkinfo@jkchemical.com
Meryer (Shanghai) Chemical Technology Co., Ltd.
Tel
4006608290; 18621169109
Email
market03@meryer.com
3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Email
3bsc@sina.com
Wuhan Chemwish Technology Co., Ltd
Tel
86-027-67849912
Email
sales@chemwish.com
Nanjing Chemlin Chemical Co., Ltd
Tel
025-83697070
Email
info@chemlin.com.cn